Coronary heart disease in type 2 diabetes mellitus in Isfahan, Iran: Prevalence and risk factors

Acta Cardiologica

Volumn 61, Issue 1, 2006, Pages 13-20

  Janghorbani, Mohsen ^a   Amini, Masoud ^a   Tavassoli, Aliakbar ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Complications; Coronary heart disease; Diabetes mellitus; Iran; Prevalence; Risk factors

Indexed keywords

INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANGINA PECTORIS; ARTICLE; BODY MASS; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; GENDER; HUMAN; INSULIN TREATMENT; IRAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SELF REPORT; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BODY MASS INDEX; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IRAN; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS;

EID: 32044473334     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.61.1.2005135     Document Type: Article

References (31)

1. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 1979; 2: 120-6.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
3. nd ed. Washington, DC: Government Printing Office; 1995: 429-48 (NIH publication no. 95-1468).
4. Laakso M. Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus. Ann Med 1996; 28: 341-5.
5. Garg A. Treatment of diabetic dyslipidemia. Am J Cardiol 1998; 81: 47B-51B.
6. Kreisberg RA. Diabetic dyslipidemia. Am J Cardiol 1998; 82: 67U-73U; 85U-86U.
7. Haffner SM. Management of dyslipidemia in adults with diabetes. Diabetes Care 1998; 21: 160-78.
8. Haffner SM, Alexander CM, Cook TJ, Boccuzzi SJ, Musliner TA, Pedersen TR, Kjekshus J, Pyörälä K. Reduced coronary events in simvastatin-treated subjects with coronary heart disease and diabetes or impaired fasting glucose: subgroup analyses in the Scandinavian Simvastatin Survival Study (4S). Arch Int Med 1999; 159: 2661-7.
9. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-13.
10. Wannamethee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart 2004; 90: 1398-403.
11. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34.
12. Mukamal KJ, Nesto RW, Cohen MC, Muller JE, Maclure M, Sherwood JB, Mittleman MA. Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care 2001; 24: 1422-7.
13. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, Piegas L, Calvin J, Keltai M, Budaj A. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: result of the OASIS (organization to assess strategies for ischemic syndromes) registry. Circulation 2000; 102: 1014-9.
14. Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol 2002; 40: 954-60.
15. Becker A, Bos G, de Vegt F, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease: 10-year follow-up of the Hoorn Study. Eur Heart J 2003; 24: 1406-13.
16. Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, Nathan DM, Manson JE. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years follow-up. Arch Intern Med 2001; 161: 1717-23.
17. Janghorbani M, Amini M, Ghanbari H, Safaiee H. Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran. Ophthalmic Epidemiol 2003; 10: 81-95.
18. Janghorbani M, Amini M. Cataract in type 2 diabetes mellitus in Isfahan, Iran: Incidence and risk factors. Ophthalmic Epidemiol 2004; 11: 347-58.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. World Health Organization. Diabetes mellitus: report of a WHO study group. Technical report series 727. WHO, Geneva 1985.
21. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
22. nd ed. Geneva, Switzerland: World Health Organization, 1982.
23. Sarraf-Zadegan N, Sayed-Tabatabaei FA, Bashardoost N, Maleki A, Totonchi M, Habibi HR, Sotodehmaram E, Tafazoli F, Karimi A. The prevalence of coronary artery disease in an urban population in Isfahan, Iran. Acta Cardiol 1999; 54: 257-63.
24. Arteagoitia JM, Larranaga MI, Rodriguez JL, Fernandez I, Finies JA. Incidence, prevalence and coronary heart disease risk level in known Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia 2003; 46: 899-909.
25. Chi ZS, Lee ET, Lu M, Keen H, Bennett PH. Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44 (Suppl 2): S82-6.
26. Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics. Diabetologia 1985; 28 (Suppl): 615-40.
27. UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 1990; 13: 1-11.
28. Uusitupa M, Siitonen O, Pyorala K, Aro A, Hersio K, Penttila I, Voutilainen E. The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin-dependent) diabetes. Diabetologia 1985; 28: 653-9.
29. UK Prospective Diabetes Study 6. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
30. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner S, Pyorala K, Tuomilehto J, for the FINMONICA Myocardial Infarction Register Study Group. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care 1998; 21: 69-75.
31. American Heart Association 1993 Heart and Stroke Facts Statistics. Dallas, Tex: National Center; 1992. AHA publication 55-0502 (COM).